array:19 [
  "pii" => "X2013251407021339"
  "issn" => "20132514"
  "estado" => "S300"
  "fechaPublicacion" => "2007-06-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia (English Version). 2007;27:340-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2643
    "formatos" => array:3 [
      "EPUB" => 245
      "HTML" => 2044
      "PDF" => 354
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:16 [
      "pii" => "X0211699507021331"
      "issn" => "02116995"
      "estado" => "S300"
      "fechaPublicacion" => "2007-06-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2007;27:340-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 6218
        "formatos" => array:3 [
          "EPUB" => 239
          "HTML" => 5284
          "PDF" => 695
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "titulo" => "Estudio de dos cohortes de pacientes para evaluar el índice de resistencia a epoetina alfa y a darbepoetin alfa en pacientes en hemodiálisis crónica"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "340"
            "paginaFinal" => "349"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Resistance index to epoetin alfa and to darbepoetin-alfa in chronic hemodialysis patients: a cohort study"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Rafael Perez-Garcia Nefrologia H.U. Gregorio Marañon, Patrocinio Rodríguez Benítez Nefrologia H.U. Gregorio Marañon, Rosa Jofre Nefrologia H.U. Grego"
            "autores" => array:1 [
              0 => array:1 [
                "nombre" => "Rafael Perez-Garcia Nefrologia H.U. Gregorio Marañon, Patrocinio Rodríguez Benítez Nefrologia H.U. Gregorio Marañon, Rosa Jofre Nefrologia H.U. Grego"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:8 [
          "pii" => "X2013251407021339"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021339?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021331?idApp=UINPBA000064"
      "url" => "/02116995/0000002700000003/v0_201502091326/X0211699507021331/v0_201502091326/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251407021312"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-06-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2007;27:350-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2965
      "formatos" => array:3 [
        "EPUB" => 282
        "HTML" => 2126
        "PDF" => 557
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "The microbial pattern of the catheter exit-site infection in peritoneal dialysis: A non-diphteria Corynebacteria emergence?"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "350"
          "paginaFinal" => "358"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Patrón microbiológico de la infección del cateter peritoneal: aumento de Corynebacterium sp.?"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Josep Teixidó Planas, Nieves Arias Suárez, Laura Tarrats Velasco, Ramón Romero González"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "Josep Teixidó Planas, Nieves Arias Suárez, Laura Tarrats Velasco, Ramón Romero González"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699507021315"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021315?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021312?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000003/v0_201502091552/X2013251407021312/v0_201502091552/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251407021347"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-06-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia (English Version). 2007;27:335-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2874
      "formatos" => array:3 [
        "EPUB" => 232
        "HTML" => 2126
        "PDF" => 516
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "INTEGRAL MANAGEMENT OF VASCULAR ACCESS BY NEPROLOGIST. THREE YEARS WORK OUTCOME"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "335"
          "paginaFinal" => "339"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "GESTION INTEGRAL DEL ACCESO VASCULAR POR LOS NEFROLOGOS.RESULTADOS DE TRES AÑOS DE TRABAJO."
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "G. García-Trío, M. Alonso, J. Saavedra, S. Cigarrán(*), J.M. Lamas"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "G. García-Trío, M. Alonso, J. Saavedra, S. Cigarrán(*), J.M. Lamas"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X021169950702134X"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950702134X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021347?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000003/v0_201502091552/X2013251407021347/v0_201502091552/en/main.assets"
  ]
  "en" => array:10 [
    "idiomaDefecto" => true
    "titulo" => "Resistance index to epoetin alfa and to darbepoetin-alfa in chronic hemodialysis patients: a cohort study"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "340"
        "paginaFinal" => "349"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "Rafael Perez-Garcia Nefrologia H.U. Gregorio Marañon, Patrocinio Rodríguez Benítez Nefrologia H.U. Gregorio Marañon, Rosa Jofre Nefrologia H.U. Grego"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "Rafael Perez-Garcia Nefrologia H.U. Gregorio Marañon, Patrocinio Rodríguez Benítez Nefrologia H.U. Gregorio Marañon, Rosa Jofre Nefrologia H.U. Grego"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Estudio de dos cohortes de pacientes para evaluar el índice de resistencia a epoetina alfa y a darbepoetin alfa en pacientes en hemodiálisis crónica"
      ]
    ]
    "tienePdf" => false
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec436313"
          "palabras" => array:1 [
            0 => "darbepoetin alfa&#59; índice de resistencia&#59; eritropoyetina&#59; hemodiálisis&#59; anemia "
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec436314"
          "palabras" => array:1 [
            0 => "darbepoetin alfa&#59; resistance index&#59; epoetin&#59; hemodialysis&#59; anemia"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:1 [
        "resumen" => "The effectiveness of the erythropoietic response can be evaluated using the resistance index &#40;RI&#41; to erythropoietic agents &#40;EA&#41; that measures the relationship between the dose administered and the hemoglobin levels attained&#46; In a hemodialysis population&#44; the RI is associated with several clinical and biochemical parameters&#44; such as albumin levels&#44; C-reactive protein &#40;CRP&#41;&#44; body mass index &#40;BMI&#41; and Kt&#47;V&#46; This index therefore reflects an important group of parameters that indicate comorbidities and measures the effectiveness of the treatment received&#46; A substantial proportion of chronic hemodialysis patients show a relative resistance to human recombinant erythropoietin &#40;rHuEPO&#41; and require high doses to reach hemoglobin levels above 11 g&#47;dl&#46; Darbepoetin alfa is a new erythropoietic agent with a longer half-life than rHuEPO and greater biological activity in vivo&#46; Furthermore&#44; it remains at clinically effective plasma levels for much longer than rHuEPO&#46; This study evaluated the effect on RI of switching from epoetin alfa to darbepoetin alfa in hemodialysis patients requiring i&#46;v&#46; rHuEPO at either high &#40; &#62;10&#44;000 UI&#47;w&#41; or low &#40; <4 000 ui w doses compared to a control group receiving epoetin alfa unlike the both groups of patients who switched darbepoetin showed reduction in ri and progressive dose required with respect equivalent at treatment conversion requiring high dri week 24 was significant 23 9 lower than eri 0 p <0 01 in the group requiring low doses dri at week 24 was 13 4 lower than eri conversion p both control groups higher 0 all showed stable hemoglobin levels across study with mean between 11 5 and 3 g dl crp significantly related to albumin <0 001 in conclusion switching hemodialysis patients from epoetin alfa to darbepoetin was associated with a significant improvement ri the group of high doses ea which we consider be an important indicator effectiveness and quality treatment administered</0> </0> </4>"
      ]
      "es" => array:1 [
        "resumen" => "La efectividad de la respuesta en la estimulaci&#243;n eritropoy&#233;tica se puede expresar por el &#237;ndice de resistencia &#40;IR&#41; a los agentes estimuladores de la eritropoyesis&#44; que expresa la relaci&#243;n entre la dosis administrada del agente y las concentraciones de hemoglobina mantenidas&#46; El IR de una poblaci&#243;n en hemodi&#225;lisis se relaciona con una serie de par&#225;metros cl&#237;nicos y bioqu&#237;micos de la hemodi&#225;lisis&#44; como la concentraci&#243;n de alb&#250;mina&#44; la prote&#237;na C reactiva &#40;PCR&#41;&#44; el &#237;ndice de la masa corporal &#40;IMC&#41; y el Kt&#47;V y se presenta&#44; por tanto&#44; como un &#237;ndice de valoraci&#243;n de un conjunto muy importante de par&#225;metros que expresan la patolog&#237;a com&#243;rbida de los pacientes y la calidad del tratamiento recibido&#46; Una proporci&#243;n considerable de pacientes en hemodi&#225;lisis cr&#243;nica presentan una resistencia relativa o respuesta sub&#243;ptima a la eritropoyetina recombinante humana &#40;rHuEPO&#41;&#44; por lo que precisan dosis elevadas de esta prote&#237;na para alcanzar unas concentraciones de hemoglobina superiores a los 11 g&#47;dl&#46; Darbepoetin alfa es una nueva prote&#237;na estimuladora de la eritropoyesis con un perfil farmacocin&#233;tico caracterizado por una semivida mucho m&#225;s prolongada que la de rHuEPO y una mayor actividad biol&#243;gica in vivo&#44; permaneciendo mucho m&#225;s tiempo en plasma a concentraciones cl&#237;nicamente eficaces en comparaci&#243;n con rHuEPO&#46; El presente estudio eval&#250;a el resultado de cambiar la administraci&#243;n de epoetina alfa a darbepoetin alfa sobre la efectividad y la calidad del tratamiento&#44; determinadas mediante el IR&#44; en pacientes en hemodi&#225;lisis que requieren un tratamiento a dosis altas &#40; &#62;10&#46;000 UI&#47;sem&#41; o bajas &#40; <4000 ui sem de epoetina alfa por vía i v en comparación con un grupo control que siguió recibiendo los dos grupos pacientes cambiaron a darbepoetin se registró una disminución del ir y la dosis necesaria relación equivalente el momento conversión no fue observada precisó altas ird al final estudio semana 24 disminuyó 23 9 respecto ire 0 estadísticamente significativa p <0 01 de forma similar en el grupo tratado con dosis bajas que cambió a darbepoetin alfa se registró una disminución del ird al final estudio 13 4 respecto ire momento la conversión p ambos grupos control aumentó inicial las concentraciones hemoglobina mantuvieron estables todos los lo largo todo período seguimiento unos valores medios oscilaron entre 11 5 y 3 g dl pcr semana 24 mostraron relación significativa albúmina <0 001 en conclusión la conversión de epoetina alfa a darbepoetin pacientes hemodiálisis tuvo como resultado una mejoría significativa del ir al tratamiento los con mayores necesidades aee</0> </0> </4000>"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002700000003/v0_201502091552/X2013251407021339/v0_201502091552/en/main.assets"
  "Apartado" => null
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021339?idApp=UINPBA000064"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Resistance index to epoetin alfa and to darbepoetin-alfa in chronic hemodialysis patients: a cohort study
Estudio de dos cohortes de pacientes para evaluar el índice de resistencia a epoetina alfa y a darbepoetin alfa en pacientes en hemodiálisis crónica
Rafael Perez-Garcia Nefrologia H.U. Gregorio Marañon, Patrocinio Rodríguez Benítez Nefrologia H.U. Gregorio Marañon, Rosa Jofre Nefrologia H.U. Grego
Read
4558
Times
was read the article
872
Total PDF
3686
Total HTML
Share statistics
 array:19 [
  "pii" => "X2013251407021339"
  "issn" => "20132514"
  "estado" => "S300"
  "fechaPublicacion" => "2007-06-01"
  "documento" => "article"
  "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
  "subdocumento" => "fla"
  "cita" => "Nefrologia &#40;English Version&#41;. 2007;27:340-9"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2643
    "formatos" => array:3 [
      "EPUB" => 245
      "HTML" => 2044
      "PDF" => 354
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:16 [
      "pii" => "X0211699507021331"
      "issn" => "02116995"
      "estado" => "S300"
      "fechaPublicacion" => "2007-06-01"
      "documento" => "article"
      "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
      "subdocumento" => "fla"
      "cita" => "Nefrologia. 2007;27:340-9"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 6218
        "formatos" => array:3 [
          "EPUB" => 239
          "HTML" => 5284
          "PDF" => 695
        ]
      ]
      "es" => array:11 [
        "idiomaDefecto" => true
        "titulo" => "Estudio de dos cohortes de pacientes para evaluar el &#237;ndice de resistencia a epoetina alfa y a darbepoetin alfa en pacientes en hemodi&#225;lisis cr&#243;nica"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "tieneResumen" => array:2 [
          0 => "es"
          1 => "en"
        ]
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "340"
            "paginaFinal" => "349"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Resistance index to epoetin alfa and to darbepoetin-alfa in chronic hemodialysis patients&#58; a cohort study"
          ]
        ]
        "contieneResumen" => array:2 [
          "es" => true
          "en" => true
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Rafael Perez-Garcia Nefrologia H&#46;U&#46; Gregorio Mara&#241;on&#44; Patrocinio Rodr&#237;guez Ben&#237;tez Nefrologia H&#46;U&#46; Gregorio Mara&#241;on&#44; Rosa Jofre Nefrologia H&#46;U&#46; Grego"
            "autores" => array:1 [
              0 => array:1 [
                "nombre" => "Rafael Perez-Garcia Nefrologia H&#46;U&#46; Gregorio Mara&#241;on&#44; Patrocinio Rodr&#237;guez Ben&#237;tez Nefrologia H&#46;U&#46; Gregorio Mara&#241;on&#44; Rosa Jofre Nefrologia H&#46;U&#46; Grego"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:8 [
          "pii" => "X2013251407021339"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021339?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021331?idApp=UINPBA000064"
      "url" => "/02116995/0000002700000003/v0_201502091326/X0211699507021331/v0_201502091326/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "X2013251407021312"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-06-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2007;27:350-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2965
      "formatos" => array:3 [
        "EPUB" => 282
        "HTML" => 2126
        "PDF" => 557
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "The microbial pattern of the catheter exit-site infection in peritoneal dialysis&#58; A non-diphteria Corynebacteria emergence&#63;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "350"
          "paginaFinal" => "358"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Patr&#243;n microbiol&#243;gico de la infecci&#243;n del cateter peritoneal&#58; aumento de Corynebacterium sp&#46;&#63;"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Josep Teixid&#243; Planas&#44; Nieves Arias Su&#225;rez&#44; Laura Tarrats Velasco&#44; Ram&#243;n Romero Gonz&#225;lez"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "Josep Teixid&#243; Planas&#44; Nieves Arias Su&#225;rez&#44; Laura Tarrats Velasco&#44; Ram&#243;n Romero Gonz&#225;lez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X0211699507021315"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507021315?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021312?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000003/v0_201502091552/X2013251407021312/v0_201502091552/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "X2013251407021347"
    "issn" => "20132514"
    "doi" => " "
    "estado" => "S300"
    "fechaPublicacion" => "2007-06-01"
    "documento" => "article"
    "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/"
    "subdocumento" => "fla"
    "cita" => "Nefrologia &#40;English Version&#41;. 2007;27:335-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2874
      "formatos" => array:3 [
        "EPUB" => 232
        "HTML" => 2126
        "PDF" => 516
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "INTEGRAL MANAGEMENT OF VASCULAR ACCESS BY NEPROLOGIST&#46; THREE YEARS WORK OUTCOME"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "335"
          "paginaFinal" => "339"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "GESTION INTEGRAL DEL ACCESO VASCULAR POR LOS NEFROLOGOS&#46;RESULTADOS DE TRES A&#209;OS DE TRABAJO&#46;"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "G&#46; Garc&#237;a-Tr&#237;o&#44; M&#46; Alonso&#44; J&#46; Saavedra&#44; S&#46; Cigarr&#225;n&#40;&#42;&#41;&#44; J&#46;M&#46; Lamas"
          "autores" => array:1 [
            0 => array:1 [
              "nombre" => "G&#46; Garc&#237;a-Tr&#237;o&#44; M&#46; Alonso&#44; J&#46; Saavedra&#44; S&#46; Cigarr&#225;n&#40;&#42;&#41;&#44; J&#46;M&#46; Lamas"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "X021169950702134X"
        "doi" => " "
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950702134X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021347?idApp=UINPBA000064"
    "url" => "/20132514/0000002700000003/v0_201502091552/X2013251407021347/v0_201502091552/en/main.assets"
  ]
  "en" => array:10 [
    "idiomaDefecto" => true
    "titulo" => "Resistance index to epoetin alfa and to darbepoetin-alfa in chronic hemodialysis patients&#58; a cohort study"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "340"
        "paginaFinal" => "349"
      ]
    ]
    "autores" => array:1 [
      0 => array:2 [
        "autoresLista" => "Rafael Perez-Garcia Nefrologia H&#46;U&#46; Gregorio Mara&#241;on&#44; Patrocinio Rodr&#237;guez Ben&#237;tez Nefrologia H&#46;U&#46; Gregorio Mara&#241;on&#44; Rosa Jofre Nefrologia H&#46;U&#46; Grego"
        "autores" => array:1 [
          0 => array:1 [
            "nombre" => "Rafael Perez-Garcia Nefrologia H&#46;U&#46; Gregorio Mara&#241;on&#44; Patrocinio Rodr&#237;guez Ben&#237;tez Nefrologia H&#46;U&#46; Gregorio Mara&#241;on&#44; Rosa Jofre Nefrologia H&#46;U&#46; Grego"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Estudio de dos cohortes de pacientes para evaluar el &#237;ndice de resistencia a epoetina alfa y a darbepoetin alfa en pacientes en hemodi&#225;lisis cr&#243;nica"
      ]
    ]
    "tienePdf" => false
    "PalabrasClave" => array:2 [
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec436313"
          "palabras" => array:1 [
            0 => "darbepoetin alfa&#59; &#237;ndice de resistencia&#59; eritropoyetina&#59; hemodi&#225;lisis&#59; anemia "
          ]
        ]
      ]
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec436314"
          "palabras" => array:1 [
            0 => "darbepoetin alfa&#59; resistance index&#59; epoetin&#59; hemodialysis&#59; anemia"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:1 [
        "resumen" => "The effectiveness of the erythropoietic response can be evaluated using the resistance index &#40;RI&#41; to erythropoietic agents &#40;EA&#41; that measures the relationship between the dose administered and the hemoglobin levels attained&#46; In a hemodialysis population&#44; the RI is associated with several clinical and biochemical parameters&#44; such as albumin levels&#44; C-reactive protein &#40;CRP&#41;&#44; body mass index &#40;BMI&#41; and Kt&#47;V&#46; This index therefore reflects an important group of parameters that indicate comorbidities and measures the effectiveness of the treatment received&#46; A substantial proportion of chronic hemodialysis patients show a relative resistance to human recombinant erythropoietin &#40;rHuEPO&#41; and require high doses to reach hemoglobin levels above 11 g&#47;dl&#46; Darbepoetin alfa is a new erythropoietic agent with a longer half-life than rHuEPO and greater biological activity in vivo&#46; Furthermore&#44; it remains at clinically effective plasma levels for much longer than rHuEPO&#46; This study evaluated the effect on RI of switching from epoetin alfa to darbepoetin alfa in hemodialysis patients requiring i&#46;v&#46; rHuEPO at either high &#40; &#62;10&#44;000 UI&#47;w&#41; or low &#40; <4 000 ui w doses compared to a control group receiving epoetin alfa unlike the both groups of patients who switched darbepoetin showed reduction in ri and progressive dose required with respect equivalent at treatment conversion requiring high dri week 24 was significant 23 9 lower than eri 0 p <0 01 in the group requiring low doses dri at week 24 was 13 4 lower than eri conversion p both control groups higher 0 all showed stable hemoglobin levels across study with mean between 11 5 and 3 g dl crp significantly related to albumin <0 001 in conclusion switching hemodialysis patients from epoetin alfa to darbepoetin was associated with a significant improvement ri the group of high doses ea which we consider be an important indicator effectiveness and quality treatment administered</0> </0> </4>"
      ]
      "es" => array:1 [
        "resumen" => "La efectividad de la respuesta en la estimulaci&#243;n eritropoy&#233;tica se puede expresar por el &#237;ndice de resistencia &#40;IR&#41; a los agentes estimuladores de la eritropoyesis&#44; que expresa la relaci&#243;n entre la dosis administrada del agente y las concentraciones de hemoglobina mantenidas&#46; El IR de una poblaci&#243;n en hemodi&#225;lisis se relaciona con una serie de par&#225;metros cl&#237;nicos y bioqu&#237;micos de la hemodi&#225;lisis&#44; como la concentraci&#243;n de alb&#250;mina&#44; la prote&#237;na C reactiva &#40;PCR&#41;&#44; el &#237;ndice de la masa corporal &#40;IMC&#41; y el Kt&#47;V y se presenta&#44; por tanto&#44; como un &#237;ndice de valoraci&#243;n de un conjunto muy importante de par&#225;metros que expresan la patolog&#237;a com&#243;rbida de los pacientes y la calidad del tratamiento recibido&#46; Una proporci&#243;n considerable de pacientes en hemodi&#225;lisis cr&#243;nica presentan una resistencia relativa o respuesta sub&#243;ptima a la eritropoyetina recombinante humana &#40;rHuEPO&#41;&#44; por lo que precisan dosis elevadas de esta prote&#237;na para alcanzar unas concentraciones de hemoglobina superiores a los 11 g&#47;dl&#46; Darbepoetin alfa es una nueva prote&#237;na estimuladora de la eritropoyesis con un perfil farmacocin&#233;tico caracterizado por una semivida mucho m&#225;s prolongada que la de rHuEPO y una mayor actividad biol&#243;gica in vivo&#44; permaneciendo mucho m&#225;s tiempo en plasma a concentraciones cl&#237;nicamente eficaces en comparaci&#243;n con rHuEPO&#46; El presente estudio eval&#250;a el resultado de cambiar la administraci&#243;n de epoetina alfa a darbepoetin alfa sobre la efectividad y la calidad del tratamiento&#44; determinadas mediante el IR&#44; en pacientes en hemodi&#225;lisis que requieren un tratamiento a dosis altas &#40; &#62;10&#46;000 UI&#47;sem&#41; o bajas &#40; <4000 ui sem de epoetina alfa por vía i v en comparación con un grupo control que siguió recibiendo los dos grupos pacientes cambiaron a darbepoetin se registró una disminución del ir y la dosis necesaria relación equivalente el momento conversión no fue observada precisó altas ird al final estudio semana 24 disminuyó 23 9 respecto ire 0 estadísticamente significativa p <0 01 de forma similar en el grupo tratado con dosis bajas que cambió a darbepoetin alfa se registró una disminución del ird al final estudio 13 4 respecto ire momento la conversión p ambos grupos control aumentó inicial las concentraciones hemoglobina mantuvieron estables todos los lo largo todo período seguimiento unos valores medios oscilaron entre 11 5 y 3 g dl pcr semana 24 mostraron relación significativa albúmina <0 001 en conclusión la conversión de epoetina alfa a darbepoetin pacientes hemodiálisis tuvo como resultado una mejoría significativa del ir al tratamiento los con mayores necesidades aee</0> </0> </4000>"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000002700000003/v0_201502091552/X2013251407021339/v0_201502091552/en/main.assets"
  "Apartado" => null
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407021339?idApp=UINPBA000064"
]
Article information
ISSN: 20132514
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 6 0 6
2024 October 33 0 33
2024 September 45 0 45
2024 August 46 0 46
2024 July 41 0 41
2024 June 39 0 39
2024 May 42 0 42
2024 April 32 0 32
2024 March 32 3 35
2024 February 24 13 37
2024 January 26 8 34
2023 December 16 8 24
2023 November 19 8 27
2023 October 18 11 29
2023 September 15 13 28
2023 August 26 5 31
2023 July 21 6 27
2023 June 24 6 30
2023 May 26 12 38
2023 April 17 10 27
2023 March 13 6 19
2023 February 19 7 26
2023 January 23 17 40
2022 December 28 16 44
2022 November 26 12 38
2022 October 30 13 43
2022 September 32 11 43
2022 August 22 16 38
2022 July 28 17 45
2022 June 21 6 27
2022 May 18 13 31
2022 April 20 10 30
2022 March 24 23 47
2022 February 24 16 40
2022 January 27 18 45
2021 December 23 15 38
2021 November 28 10 38
2021 October 72 17 89
2021 September 48 11 59
2021 August 52 9 61
2021 July 28 13 41
2021 June 17 9 26
2021 May 28 5 33
2021 April 45 13 58
2021 March 42 28 70
2021 February 53 7 60
2021 January 20 8 28
2020 December 26 12 38
2020 November 24 3 27
2020 October 21 7 28
2020 September 24 6 30
2020 August 35 1 36
2020 July 27 8 35
2020 June 19 2 21
2020 May 27 9 36
2020 April 31 11 42
2020 March 28 7 35
2020 February 46 11 57
2020 January 48 4 52
2019 December 35 7 42
2019 November 26 8 34
2019 October 10 2 12
2019 September 21 10 31
2019 August 20 11 31
2019 July 26 8 34
2019 June 18 1 19
2019 May 8 5 13
2019 April 36 7 43
2019 March 23 5 28
2019 February 7 6 13
2019 January 11 10 21
2018 December 29 17 46
2018 November 38 7 45
2018 October 33 12 45
2018 September 33 10 43
2018 August 18 9 27
2018 July 17 13 30
2018 June 11 11 22
2018 May 22 13 35
2018 April 17 7 24
2018 March 16 6 22
2018 February 17 28 45
2018 January 13 6 19
2017 December 15 9 24
2017 November 11 6 17
2017 October 11 8 19
2017 September 12 31 43
2017 August 22 5 27
2017 July 16 7 23
2017 June 10 7 17
2017 May 9 2 11
2017 April 14 25 39
2017 March 10 2 12
2017 February 12 4 16
2017 January 5 3 8
2016 December 32 2 34
2016 November 34 4 38
2016 October 44 7 51
2016 September 50 1 51
2016 August 111 0 111
2016 July 108 0 108
2016 June 73 0 73
2016 May 86 0 86
2016 April 56 0 56
2016 March 58 0 58
2016 February 69 0 69
2016 January 64 0 64
2015 December 97 0 97
2015 November 73 0 73
2015 October 66 0 66
2015 September 50 0 50
2015 August 80 0 80
2015 July 61 0 61
2015 June 31 0 31
2015 May 64 0 64
2015 April 12 0 12
Show all

Follow this link to access the full text of the article

Idiomas
Nefrología (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?